Capital Asset Advisory Services’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,245	Closed	-$267K	–	713
2021 Q2	$267K	Sell	4,245 -222	-5%	-$14.3K	0.03%	379
2021 Q1	$415K	Sell	4,467 -417	-9%	-$42.7K	0.06%	286
2020 Q4	$438K	Sell	4,884 -174	-3%	-$16K	0.08%	219
2020 Q3	$523K	Sell	5,058 -219	-4%	-$23.6K	0.11%	151
2020 Q2	$646K	Sell	5,277 -682	-11%	-$50.8K	0.14%	132
2020 Q1	$484K	Sell	5,959 -254	-4%	-$14.6K	0.13%	135
2019 Q4	$390K	Sell	6,213 -416	-6%	-$22.6K	0.09%	215
2019 Q3	$347K	Buy	6,629 +320	+5%	+$14.9K	0.23%	78
2019 Q2	$305K	Buy	+6,309	New	+$302K	0.24%	82
2019 Q1	–	Sell	-8,255	Closed	-$489K	–	83
2018 Q4	$489K	Sell	8,255 -453	-5%	-$29.2K	0.47%	51
2018 Q3	$573K	Buy	8,708 +326	+4%	+$19K	0.48%	48
2018 Q2	$423K	Sell	8,382 -1,441	-15%	-$75.1K	0.38%	59
2018 Q1	$517K	Sell	9,823 -360	-4%	-$17.9K	0.48%	52
2017 Q4	$473K	Sell	10,183 -2,138	-17%	-$90K	0.43%	62
2017 Q3	$498K	Sell	12,321 -65	-0.5%	-$2.35K	0.45%	56
2017 Q2	$416K	Buy	+12,386	New	+$382K	0.27%	85